Singular Genomics Systems Inc. (OMIC) Financial Statements (2024 and earlier)

Company Profile

Business Address 3010 SCIENCE PARK ROAD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:173,900244,600339,200
Cash and cash equivalents16,23374,266201,049
Short-term investments157,708170,310138,174
Other undisclosed cash, cash equivalents, and short-term investments(41)24(23)
Receivables565913 
Inventory, net of allowances, customer advances and progress billings13,57218,2213,011
Inventory13,57218,2213,011
Prepaid expense1,6723,0033,715
Deposits current assets1,459620761
Other undisclosed current assets1,0601,0751,073
Total current assets:192,228268,432347,760
Noncurrent Assets
Operating lease, right-of-use asset57,79745,896 
Property, plant and equipment13,69210,7846,072
Restricted cash and investments6001,711687
Other noncurrent assets1,1501,1521,129
Total noncurrent assets:73,23959,5437,888
TOTAL ASSETS:265,467327,975355,648
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,6667,6826,626
Accounts payable2,5873,0992,348
Accrued liabilities6,0794,5834,278
Deferred revenue   
Debt1,312  
Other liabilities1,857113118
Other undisclosed current liabilities6,4526,323 
Total current liabilities:18,28714,1186,744
Noncurrent Liabilities
Long-term debt and lease obligation8,90110,0659,904
Long-term debt, excluding current maturities8,90110,0659,904
Liabilities, other than long-term debt59,27343,4712,827
Other liabilities6501,0152,827
Operating lease, liability58,62342,456 
Total noncurrent liabilities:68,17453,53612,731
Total liabilities:86,46167,65419,475
Equity
Equity, attributable to parent179,006260,321336,173
Common stock777
Additional paid in capital516,439503,926488,200
Accumulated other comprehensive income (loss)155(837)(138)
Accumulated deficit(337,595)(242,775)(151,896)
Total equity:179,006260,321336,173
TOTAL LIABILITIES AND EQUITY:265,467327,975355,648

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
Revenues2,911765 
Cost of revenue(3,469)(789) 
Gross profit:(558)(24) 
Operating expenses(102,243)(93,463)(61,279)
Operating loss:(102,801)(93,487)(61,279)
Nonoperating income
(Other Nonoperating income)
7,9812,608405
Interest and debt expense(1,101)(763)(846)
Loss from continuing operations:(95,921)(91,642)(61,720)
Loss before gain (loss) on sale of properties:(61,720)
Other undisclosed net income (loss)1,101763(37,051)
Net loss:(94,820)(90,879)(98,771)
Other undisclosed net income attributable to parent   
Net loss available to common stockholders, diluted:(94,820)(90,879)(98,771)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
Net loss:(94,820)(90,879)(98,771)
Comprehensive loss:(94,820)(90,879)(98,771)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent992(699)(155)
Comprehensive loss, net of tax, attributable to parent:(93,828)(91,578)(98,926)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: